Xavier Durando

9PUBLICATIONS
20CO-AUTHORS
Pacific Peoples theory of change models for healthCancer therapy (excl. chemotherapy and radiation therapy)Fairness, accountability, transparency, trust and ethics of computer systemsNanotoxicology, health and safetyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 20, 2025
Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial.

Angeline Ginzac, Emmanuelle Bourbouloux, Romain Rivoirard

|Mar 07, 2024
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.

Angeline Ginzac, Ioana Molnar, Xavier Durando

|Feb 24, 2024
Consore: A Powerful Federated Data Mining Tool Driving a French Research Network to Accelerate Cancer Research.

Julien Guérin, Amine Nahid, Louis Tassy

|Dec 23, 2023
A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules.

François Ducray, Carole Ramirez, Marie Robert

|Jul 03, 2023
Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial.

Angeline Ginzac, Marie-Céleste Ferreira, Anne Cayre

|Jun 08, 2023
Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab.

Nathan El-Ghazzi, Xavier Durando, Alexia Giro

Pageof 2

Frequent Collaborators

5 joint publications

Angeline Ginzac

4 joint publications

Ioana Molnar

2 joint publications

Hugo Veyssiere

2 joint publications

Maureen Bernadach